Invention Grant
- Patent Title: Methods of treating an IL-17A mediated pathological condition
-
Application No.: US14695677Application Date: 2015-06-29
-
Publication No.: US09771420B2Publication Date: 2017-09-26
- Inventor: Thomas Allen Ceska , Alistar James Henry , Jiye Shi
- Applicant: UCB BIOPHARMA SPRL
- Applicant Address: BE Brussels
- Assignee: UCB BIOPHARMA SPRL
- Current Assignee: UCB BIOPHARMA SPRL
- Current Assignee Address: BE Brussels
- Agency: Marshall, Gerstein & Borun LLP
- Priority: GB0807413.0 20080423
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24 ; C07K14/54
Abstract:
The present invention relates neutralizing epitopes of IL-17A and IL-17F and antibodies which bind those epitopes. The present invention also relates to the therapeutic uses of the antibody molecules and methods for producing them.
Public/Granted literature
- US20150315272A1 Epitopes of IL-17A and IL-17F And Antibodies Specific Thereto Public/Granted day:2015-11-05
Information query
